Inhibitory effects of nondigestible carbohydrates of different chain lengths on azoxymethane-induced aberrant crypt foci in Fisher 344 rats

Nutrition Research

Volumn 25, Issue 9, 2005, Pages 859-868

  Verghese, Martha ^a   Walker, Lloyd T ^a   Shackelford, Louis ^a   Chawan, Chandramohan B ^a  

^a ALABAMA A AND M UNIVERSITY   (United States)

Author keywords

ACFs, aberrant crypt foci; AOM, azoxymethane; Fructo oligosaccharides; Rat; SCFAs, short chain fatty acids

Indexed keywords

AZOXYMETHANE; CARBOHYDRATE DERIVATIVE; CARBON DIOXIDE; FRUCTOSE; MALTODEXTRIN; OLIGOFRUCTOSE; PREBIOTIC AGENT; RAFTILINE HP; RAFTILINE ST; RAFTILOSE P95; RAFTILOSE SYNERGY1; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPHYXIA; BODY WEIGHT; CECUM; COLON; COLON INJURY; CONTROLLED STUDY; DIET; DIETARY INTAKE; FEEDING; MALE; NONHUMAN; ORGAN WEIGHT; PH; PRECANCER; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALIA;

EID: 26844448331     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2005.09.007     Document Type: Article

References (29)

1. S.L. Parker, T. Tong, S. Bolden, and P.A. Wings Cancer statistics CA Cancer J Clin 47 Suppl 1 1997 5 27
2. J.D. Potter Risk factors for colon neoplasia. Epidemiology and biology Eur J Cancer 23 1995 1210 1220
3. A. Agarwal, H. Shen, S. Agarwal, and A.V. Rao Lycopene content of tomato products: its stability, bioavailability and in vivo antioxidant properties J Med Food 4 1 2001 9 15
4. S. Franceschi, F. Levi, and C. La Vecchia Epidemiology of gastric cancer in Europe Eur J Cancer Prev 2 Suppl 2 1994 5 10
5. H. Gerster The potential role of lycopene for human health J Am Coll Nutr 16 2 1997 109 126
6. E. Giovannucci, A. Ascherio, E.B. Rimm, M.J. Stampfer, G.A. Colditz, and W.C. Willett Intake of carotenoids and retinol in relation to risk of prostate cancer J Natl Cancer Inst 87 1995 1767 1776
7. B.S. Reddy Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth J Nutr 129 1999 1478S 1482S
8. B.S. Reddy, R. Hamid, and C.V. Rao Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition Carcinogenesis 18 1997 1371 1374
9. I.R. Rowland, C.J. Rumney, J.T. Coutts, and L. Lievense Effects of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen induced aberrant crypt foci in rats Carcinogenesis 19 1998 281 285
10. H. Taper, N. Delzenne, and M.B. Roberfroid Growth inhibition of transplantable mouse tumours by non digestible carbohydrates Int J Cancer 71 1997 1109 1112
11. H. Taper, and M.B. Roberfroid Influence of inulin and oligofructose on breast cancer and tumor growth J Nutr 129 1999 1488S 1491S
12. M. Verghese, D.R. Rao, C.B. Chawan, and L. Shackelford Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats J Nutr 132 2002 2809 2813
13. M. Verghese, D.R. Rao, C.B. Chawan, L.L. Williams, and L. Shackelford Dietary inulin suppresses azoxymethane-induced aberrant crypt foci and colon tumors at promotion stage in Fisher 344 rats J Nutr 132 2002 2804 2808
14. H. Hidaka, T. Eida, T. Takizawa, T. Tokunaga, and Y. Tashiro Effects of fructooligosaccharides on intestinal flora and human health Bifidibact Microflora 5 1986 37
15. T. Mitsuoka, H. Hidaka, and T. Eida Effect of fructo-oligosaccharides on intestinal microflora Nahrung 31 1987 427 436
16. J. Van Loo, and N. Jonkers Evaluation in human volunteers of the potential anticarcinogenic activities of novel nutritional concepts: prebiotics probiotics and synbiotics (the SYNCAN project) Nutr Metab Cardiovasc Dis 11 2001 87 93
17. R.P. Bird Observation and quantification of aberrant crypt foci in murine colon treated with a colon carcinogen: preliminary findings Cancer Lett 37 1987 147 151
18. R.P. Bird, and C.K. Good The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer Toxicol Lett 112-113 2000 395 402
19. M.J. Wargovich, A. Jimenez, K. McKee, V.E. Steele, M. Velasco, and J. Woods Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression Carcinogenesis 21 6 2000 1149 1155
20. W.Y. Siu, T. Arooz, and R.Y. Poon Differential responses of proliferating versus quiescent cells to adriamycin Exp Cell Res 250 1 1999 131 141
21. T.P. Pretlow, M.A. O'Riordan, T.G. Pretlow, and T.A. Stellato Aberrant crypts in human colonic mucosa: putative preneoplastic lesions J Cell Biochem 16G Suppl 1992 55 62
22. T.P. Pretlow, M.A. O'Riordan, G.A. Somich, and T.G. Pretlow Aberrant crypts correlate with tumor incidence in Fisher344 rats treated with azoxymethane and phytate Carcinogenesis 13 1992 1509 1512
23. P.G. Reeves, F.H. Nielsen, and G.C. Fahey Jr. AIN-93 purified diet for laboratory rodents: final report of the American Institute of Nutrition adhoc writing committee on the reformulation of the AIN-76A rodent diet J Nutr 123 1993 1939 1951
24. SAS. Statistical Analysis Systems, Inc. Cary (NC); 1997.
25. J.M. Campbell, G.C. Fahey, and B.W. Wolf Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats J Nutr 127 1997 30 136
26. M.A. Roberfroid A functional food-chicory fructo-oligosaccharide: a colonic food with prebiotic activity World Ingred 1995 42 44
27. G.R. Gibson, and M.B. Roberfroid Dietary modulation of the human colonic microbiota-introducing the concept of prebiotics J Nutr 125 1995 1401 1412
28. A. Challa, D.R. Rao, C.B. Chawan, and L. Shackelford Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats Carcinogenesis 18 1997 517 521
29. N. Kulkarni, and B.S. Reddy Inhibitory effect of Bifidobacterium longum cultures on azoxymethane-induced aberrant crypt foci formation and fecal bacterial β-glucuronidase Proc Soc Exp Biol Med 207 1994 278 283